These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24218291)

  • 21. Insight into the oseltamivir resistance R292K mutation in H5N1 influenza virus: a molecular docking and molecular dynamics approach.
    Karthick V; Ramanathan K
    Cell Biochem Biophys; 2014 Mar; 68(2):291-9. PubMed ID: 23794010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.
    Kannan S; Kolandaivel P
    J Biomol Struct Dyn; 2018 Dec; 36(16):4255-4269. PubMed ID: 29199545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
    Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir.
    Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
    Protoplasma; 2013 Feb; 250(1):197-207. PubMed ID: 22392098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses.
    Yen HL; Hoffmann E; Taylor G; Scholtissek C; Monto AS; Webster RG; Govorkova EA
    J Virol; 2006 Sep; 80(17):8787-95. PubMed ID: 16912325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of avian influenza A (H9N2) virus with reduced susceptibility to neuraminidase inhibitors oseltamivir and zanamivir.
    Kode SS; Pawar SD; Cherian SS; Tare DS; Bhoye D; Keng SS; Mullick J
    Virus Res; 2019 May; 265():122-126. PubMed ID: 30910698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.
    Yamada H; Nagao C; Haredy AM; Mori Y; Mizuguchi K; Yamanishi K; Okamoto S
    Antiviral Res; 2014 Nov; 111():69-77. PubMed ID: 25234090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
    Li L; Li Y; Zhang L; Hou T
    J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes.
    Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.
    Hsu KC; Hung HC; HuangFu WC; Sung TY; Eight Lin T; Fang MY; Chen IJ; Pathak N; Hsu JT; Yang JM
    Sci Rep; 2017 Sep; 7(1):12336. PubMed ID: 28951584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.
    L'Huillier AG; Abed Y; Petty TJ; Cordey S; Thomas Y; Bouhy X; Schibler M; Simon A; Chalandon Y; van Delden C; Zdobnov E; Boquete-Suter P; Boivin G; Kaiser L
    J Infect Dis; 2015 Dec; 212(11):1726-34. PubMed ID: 25985905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.
    Park JW; Jo WH
    J Chem Inf Model; 2009 Dec; 49(12):2735-41. PubMed ID: 19957991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
    Boechat Fda C; Sacramento CQ; Cunha AC; Sagrillo FS; Nogueira CM; Fintelman-Rodrigues N; Santos-Filho O; Riscado CS; Forezi Lda S; Faro LV; Brozeguini L; Marques IP; Ferreira VF; Souza TM; de Souza MC
    Bioorg Med Chem; 2015 Dec; 23(24):7777-84. PubMed ID: 26643220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
    Abed Y; Baz M; Boivin G
    Antivir Ther; 2006; 11(8):971-6. PubMed ID: 17302366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outside-binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1.
    Tolentino-Lopez L; Segura-Cabrera A; Reyes-Loyola P; Zimic M; Quiliano M; Briz V; Muñoz-Fernández A; Rodríguez-Pérez M; Ilizaliturri-Flores I; Correa-Basurto J
    Biopolymers; 2013 Jan; 99(1):10-21. PubMed ID: 23097226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.
    Shu M; Lin Z; Zhang Y; Wu Y; Mei H; Jiang Y
    J Mol Model; 2011 Mar; 17(3):587-92. PubMed ID: 20517627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.
    Mooney CA; Johnson SA; 't Hart P; Quarles van Ufford L; de Haan CA; Moret EE; Martin NI
    J Med Chem; 2014 Apr; 57(7):3154-60. PubMed ID: 24649802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.